ABDUL HALEEM KAZMI: Open Payments
NPI 1164928230 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 36 payments from 10 companies in 2025. Trend: 2023 $85 · 2024 $87 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $185 |
| Exact Sciences Corporation | 3 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| ABBVIE INC. | 3 | $47 |
| Amgen Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Pulmonx Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
Products named: CAPLYTA, Cologuard Collection Kit, BREZTRI, FANAPT, REXULTI, JARDIANCE, CHARTIS CATHETER, OTEZLA.
Industry payments across MI — which companies pay providers there.
